Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 28, 2016

 

ABBVIE INC.

(Exact name of registrant as specified in its charter)

 

---

 

Delaware		001-35565		32-0375147
(State or other Jurisdiction		(Commission File Number)		(IRS Employer
of Incorporation)				Identification No.)

 

---

 

1 North Waukegan Road

North Chicago, Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

 

Registrant’s telephone number, including area code:  [phone]

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

 

Item 2.02.  Results of Operations and Financial Condition

 

On October 28, 2016, AbbVie Inc. issued a press release announcing financial results for the third quarter ended September 30, 2016.  A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits

 

Exhibit No.		Exhibit
99.1		Press Release dated October 28, 2016 (furnished pursuant to Item 2.02).

 

2

---

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		ABBVIE INC.
Date:   October 28, 2016	By:	/s/ William J. Chase
		William J. Chase
		Executive Vice President,
		Chief Financial Officer

 

3

---

 

EXHIBIT INDEX

 

Exhibit No.		Exhibit
99.1		Press Release dated October 28, 2016 (furnished pursuant to Item 2.02).

 

4

---